Baseline tumor size is an independent prognostic factor for overall survival in patients with melanoma treated with pembrolizumab

Richard W. Joseph, Jeroen Elassaiss-Schaap, Richard Kefford, Wen Jen Hwu, Jedd D. Wolchok, Anthony M. Joshua, Antoni Ribas, F. Stephen Hodi, Omid Hamid, Caroline Robert, Adil Daud, Roxana Dronca, Peter Hersey, Jeffrey S. Weber, Amita Patnaik, Dinesh P. De Alwis, Andrea Perrone, Jin Zhang, S. Peter Kang, Scot EbbinghausKeaven M. Anderson, Tara C. Gangadhar

Research output: Contribution to journalArticlepeer-review

110 Scopus citations

Fingerprint

Dive into the research topics of 'Baseline tumor size is an independent prognostic factor for overall survival in patients with melanoma treated with pembrolizumab'. Together they form a unique fingerprint.

Medicine & Life Sciences